In the opening hour of the evening session, U.S. equity futures are down marginally, with S&P500, Nasdaq 100 and Dow Industrials all slipping 0.1% from Monday’s closing levels. In commodities, WTI Crude Oil is off by 0.2% below $65 per barrel, though the contract continues to trade in a narrow range in the wake of Israel-Iran flare-up volatility earlier this month. Precious metals are also finding support after Friday’s retreat, with Gold bounding back above $3,300 and Silver above $36 per ounce.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
On Monday, Nasdaq Composite and S&P 500 closed at fresh record highs, with Tech and Financials seen as the best performing sectors on the latter while Energy and Consumer Discretionary underperformed. Amazon (AMZN) and Tesla (TSLA) were down 2%, reflecting a more cautious sentiment on Consumer names heading into this week’s key employment data.
Fixed income markets have also foreshadowed a potentially slower-growing second half of 2025 for the economy, with yields on the 10-year U.S. Treasury falling another 5bps to a two-month low of 4.23% and expectations of Fed policy now balancing more in favor of three rate 25bp rate cuts this year.
Check out this evening’s top movers from around Wall Street, compiled by The Fly.
HIGHER
- Halozyme Therapeutics (HALO) up 2.7% after being added to Russell 1000
- Ovintiv (OVV) up 1.2% after being upgraded to Buy at Goldman Sachs
- CoreCivic (CXW) up 0.6% after being started at Buy at Texas Capital
- Geo Group (GEO) up 0.6% after being started at Buy at Texas Capital
DOWN AFTER EARNINGS
ALSO LOWER
- Dyne Therapeutics (DYN) down 9.7% after equity offering
- AeroVironment (AVAV) down 5.6% after equity offering
- Nektar Therapeutics (NKTR) down 2.1% after equity offering
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HALO:
- Halozyme added to Russell 1000 Index
- Halozyme says Argenx received EU approval for Vyvgart with Enhanze for CIDP
- PGR institution likely weakens Halozyme bull case scenario, says Wells Fargo
- Merck granted review of Halozyme patent claims by PTAB
- Halozyme’s Strategic Positioning and Market Potential Drive Buy Rating